Preparation of vancomycin microparticles: importance of preparation parameters

Walid Hachicha1, Laurent Kodjikian, Hatem Fessi

  • 1Laboratoire d'Automatique et de Génie des procédés, UMR CNRS 5007, Villeurbanne, France.

Insights

Researchers developed vancomycin-loaded microparticles for sustained intraocular drug delivery. These particles aim to maintain effective antibiotic levels for 24 hours, crucial for preventing infections after cataract surgery.

Area of Science:

  • Ophthalmology
  • Materials Science
  • Pharmacology

Background:

  • Endophthalmitis is a serious risk following cataract surgery.
  • Maintaining adequate intracameral antibiotic levels is critical for prophylaxis.
  • Current delivery methods may not ensure sustained drug release.

Purpose of the Study:

  • To prepare and characterize vancomycin-loaded poly(lactide-co-glycolide) microparticles.
  • To achieve continuous vancomycin release for at least 24 hours post-injection.
  • To ensure suitability for intraocular use in endophthalmitis prophylaxis.

Main Methods:

  • Preparation of microparticles using the double emulsion (water-in-oil-in-water) solvent extraction/evaporation method.
  • Exploration of preparation parameters to control particle size, stability, and encapsulation rate.
  • Evaluation of vancomycin release profiles and microparticle stability.

Main Results:

  • Successfully prepared vancomycin-loaded poly(lactide-co-glycolide) microparticles.
  • Achieved controlled particle sizes and encapsulation rates through experimental design.
  • Demonstrated satisfying release profiles and stability, suitable for intraocular administration.
  • Microparticle properties were found to be independent of the specific preparation process.

Conclusions:

  • The fabricated vancomycin microparticles show promise for intraocular prophylaxis after cataract surgery.
  • The controlled release profile and stability meet the requirements for sustained therapeutic effect.
  • Further in vitro and in vivo studies are warranted to confirm efficacy and clinical utility.